Journal profile · Biochemistry & Molecular Biology
Journal of Cellular Biochemistry
ISSN 0730-2312 · eISSN 1097-4644 · Wiley-Liss Inc. · UNITED STATES · Semimonthly · Founded 1982
Journal of Cellular Biochemistry: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 3.01; hybrid open access; APC about USD 5,110; median 118 days to acceptance (52 articles, last 24 months); community-reported acceptance: about 95%; 106 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Journal of Cellular Biochemistry is published by Wiley-Liss Inc. and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and RNA Research and Splicing, together about 21.1% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Cellular Biochemistry publishes descriptions of original research in which complex cellular, pathogenic, clinical, or animal model systems are studied by biochemical, molecular, genetic, epigenetic or quantitative ultrastructural approaches. Submission of papers reporting genomic, proteomic, bioinformatics and systems biology approaches to identify and characterize parameters of biological control in a cellular context are encouraged. The areas covered include, but are not restricted to, conditions, agents, regulatory networks, or differentiation states that influence structure, cell cycle & growth control, structure-function relationships.
Source: LetPub
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology7.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology7.3%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology6%
- Bone Metabolism and DiseasesBiochemistry, Genetics and Molecular Biology5.8%
- Cell Adhesion Molecules ResearchMedicine5.4%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5.4%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology5.2%
- Cancer-related Molecular PathwaysMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2020 edition (high risk); not listed in the other 5 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.01LetPub ·
- CiteScore 2026-06
- 7.4LetPub ·
- SJR 2026-06
- 0.91LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 151LetPub ·
- h-index
- 228OpenAlex ·
- i10-index
- 10,957OpenAlex ·
- 2-year mean citedness
- 2.81OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 19.06%LetPub ·
Volume
- Articles per year
- 49LetPub ·
Articles by year OpenAlex count · 16,523 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 57 | 31 | 9 |
| 2025 | 106 | 55 | 143 |
| 2024 | 171 | 95 | 787 |
| 2023 | 167 | 93 | 1,298 |
| 2022 | 178 | 45 | 2,010 |
| 2021 | 329 | 155 | 2,476 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
118 daysMedian, submission to acceptance · P25–P75 73 days – 150 days
- Acceptance to online
- median 13 days (52 articles)
- Submission to online
- median 135 days
- Sample
- 52 articles with submission and acceptance dates (185 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,110 / EUR 4,210 / GBP 3,400 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Liss Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1982
- ISSN
- 0730-2312
- Electronic ISSN
- 1097-4644
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Cellular Biochemistry
What CAS zone is Journal of Cellular Biochemistry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cellular Biochemistry is in Zone 3 of Biology, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Cell Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cellular Biochemistry?
The latest impact factor listed by LetPub is 3.01; CiteScore 7.4, h-index 228.
How long does peer review take at Journal of Cellular Biochemistry?
Based on the dates recorded on 52 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 118 days (interquartile range 73–150 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Cellular Biochemistry?
According to LetPub and DOAJ records, Journal of Cellular Biochemistry is indexed in SCIE and Scopus.
Is Journal of Cellular Biochemistry open access, and what is the APC?
Journal of Cellular Biochemistry is a hybrid journal. For open-access publication: APC about USD 5,110.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .